FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2924734345> ?p ?o ?g. }

• W2924734345 endingPage "44" @default.
• W2924734345 startingPage "39" @default.
• W2924734345 abstract "Currently, the number of patients treated with immune-checkpoint inhibitor involving nivolumab is increasing. Nevertheless, it causes various immune-related adverse events (irAEs). Here, we report the case of a patient who underwent long-term follow-up after suffering from nivolumab-associated colitis. The patient was a 57-year-old man who underwent resection of a bladder tumor. Following surgery, lymph node metastasis was detected, and he was treated by nivolumab. Two months after treatment with nivolumab, the patient complained of bloody diarrhea. Colonoscopy revealed pancolitis with erosions, loss of vascular pattern and erythema. Pathological findings indicated a disease state of pan-ulcerative colitis. As an irAE by nivolumab, the patient was started with 30 mg of prednisolone. Prednisolone treatment successfully induced clinical remission and mucosal healing. Nevertheless, eight months after stopping the steroid treatment, the colitis relapsed with diarrhea following elevation of fecal immunochemical test (FIT) and fecal calprotectin (CPT). The relapsed colitis was treated by mesalazine, and then diarrhea was improved. Nivolumab-associated colitis relapsed following mucosal healing suggesting that it is necessary to consider maintenance therapy as well as remission induction for long-term survivor. The present case also demonstrates that the FIT and CPT would be effective biomarker to assess the disease activity of nivolumab-associated colitis." @default.
• W2924734345 created "2019-04-01" @default.
• W2924734345 creator A5002456826 @default.
• W2924734345 creator A5003370992 @default.
• W2924734345 creator A5005501709 @default.
• W2924734345 creator A5017660646 @default.
• W2924734345 creator A5025820520 @default.
• W2924734345 creator A5030059989 @default.
• W2924734345 creator A5036210422 @default.
• W2924734345 creator A5049534669 @default.
• W2924734345 creator A5069891524 @default.
• W2924734345 creator A5078213234 @default.
• W2924734345 creator A5084850341 @default.
• W2924734345 creator A5085554839 @default.
• W2924734345 creator A5086129189 @default.
• W2924734345 creator A5089343885 @default.
• W2924734345 date "2019-01-02" @default.
• W2924734345 modified "2023-09-27" @default.
• W2924734345 title "A case of nivolumab-associated colitis, which relapsed after mucosal healing and was then successfully treated with mesalazine" @default.
• W2924734345 cites W1538902372 @default.
• W2924734345 cites W1985401118 @default.
• W2924734345 cites W2060070314 @default.
• W2924734345 cites W2106511606 @default.
• W2924734345 cites W2135885240 @default.
• W2924734345 cites W2463439384 @default.
• W2924734345 cites W2549481046 @default.
• W2924734345 cites W2551653151 @default.
• W2924734345 cites W2595325983 @default.
• W2924734345 cites W2598121793 @default.
• W2924734345 cites W2746991247 @default.
• W2924734345 cites W2778022170 @default.
• W2924734345 cites W2780567639 @default.
• W2924734345 cites W2791043965 @default.
• W2924734345 cites W2794510318 @default.
• W2924734345 cites W2895326014 @default.
• W2924734345 doi "https://doi.org/10.1080/25785826.2019.1580477" @default.
• W2924734345 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30917094" @default.
• W2924734345 hasPublicationYear "2019" @default.
• W2924734345 type Work @default.
• W2924734345 sameAs 2924734345 @default.
• W2924734345 citedByCount "10" @default.
• W2924734345 countsByYear W29247343452019 @default.
• W2924734345 countsByYear W29247343452020 @default.
• W2924734345 countsByYear W29247343452021 @default.
• W2924734345 countsByYear W29247343452022 @default.
• W2924734345 countsByYear W29247343452023 @default.
• W2924734345 crossrefType "journal-article" @default.
• W2924734345 hasAuthorship W2924734345A5002456826 @default.
• W2924734345 hasAuthorship W2924734345A5003370992 @default.
• W2924734345 hasAuthorship W2924734345A5005501709 @default.
• W2924734345 hasAuthorship W2924734345A5017660646 @default.
• W2924734345 hasAuthorship W2924734345A5025820520 @default.
• W2924734345 hasAuthorship W2924734345A5030059989 @default.
• W2924734345 hasAuthorship W2924734345A5036210422 @default.
• W2924734345 hasAuthorship W2924734345A5049534669 @default.
• W2924734345 hasAuthorship W2924734345A5069891524 @default.
• W2924734345 hasAuthorship W2924734345A5078213234 @default.
• W2924734345 hasAuthorship W2924734345A5084850341 @default.
• W2924734345 hasAuthorship W2924734345A5085554839 @default.
• W2924734345 hasAuthorship W2924734345A5086129189 @default.
• W2924734345 hasAuthorship W2924734345A5089343885 @default.
• W2924734345 hasBestOaLocation W29247343451 @default.
• W2924734345 hasConcept C121608353 @default.
• W2924734345 hasConcept C126322002 @default.
• W2924734345 hasConcept C141071460 @default.
• W2924734345 hasConcept C2775862500 @default.
• W2924734345 hasConcept C2776715498 @default.
• W2924734345 hasConcept C2777044582 @default.
• W2924734345 hasConcept C2777701055 @default.
• W2924734345 hasConcept C2778260677 @default.
• W2924734345 hasConcept C2778292693 @default.
• W2924734345 hasConcept C2778435480 @default.
• W2924734345 hasConcept C2779134260 @default.
• W2924734345 hasConcept C2779174533 @default.
• W2924734345 hasConcept C2779802037 @default.
• W2924734345 hasConcept C2780030458 @default.
• W2924734345 hasConcept C2780479503 @default.
• W2924734345 hasConcept C526805850 @default.
• W2924734345 hasConcept C71924100 @default.
• W2924734345 hasConcept C90924648 @default.
• W2924734345 hasConceptScore W2924734345C121608353 @default.
• W2924734345 hasConceptScore W2924734345C126322002 @default.
• W2924734345 hasConceptScore W2924734345C141071460 @default.
• W2924734345 hasConceptScore W2924734345C2775862500 @default.
• W2924734345 hasConceptScore W2924734345C2776715498 @default.
• W2924734345 hasConceptScore W2924734345C2777044582 @default.
• W2924734345 hasConceptScore W2924734345C2777701055 @default.
• W2924734345 hasConceptScore W2924734345C2778260677 @default.
• W2924734345 hasConceptScore W2924734345C2778292693 @default.
• W2924734345 hasConceptScore W2924734345C2778435480 @default.
• W2924734345 hasConceptScore W2924734345C2779134260 @default.
• W2924734345 hasConceptScore W2924734345C2779174533 @default.
• W2924734345 hasConceptScore W2924734345C2779802037 @default.
• W2924734345 hasConceptScore W2924734345C2780030458 @default.
• W2924734345 hasConceptScore W2924734345C2780479503 @default.
• W2924734345 hasConceptScore W2924734345C526805850 @default.
• W2924734345 hasConceptScore W2924734345C71924100 @default.
• W2924734345 hasConceptScore W2924734345C90924648 @default.

• next